A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells.
about
The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradationAdoptive cell therapy for sarcomaTrypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B CellsCetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.Differential MHC class I expression in distinct leukocyte subsetsHuman tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacityMyxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT3D tissue-engineered model of Ewing's sarcomaThe ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.MicroRNA-deficient NK cells exhibit decreased survival but enhanced functionProgressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing.APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells.Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G.Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice.Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis.Differential recruitment and activation of natural killer cell sub-populations by Mycobacterium bovis-infected dendritic cells.Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.Ultrasonic three-dimensional on-chip cell culture for dynamic studies of tumor immune surveillance by natural killer cells.Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis.Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression.A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity.
P2860
Q24294989-3F7B09A4-D34A-437D-9863-BB980A70ABB7Q27009541-1B0E799F-1C10-4AFA-94D2-C9CCD67019ACQ27312822-69547874-0835-4AA7-AAE5-B899CCD7106EQ27329648-C7C41598-084E-4836-81C4-17F364271128Q30648415-AD8FC9E5-2A48-4F37-BD58-6D7F09BCBAE6Q33962604-BDFDC22B-E84F-47F5-9593-A2814A6A1296Q34016504-3B11B972-72CC-415E-BBD8-CD8FFD7FB73AQ34031624-C1847FB8-05D5-487B-AF63-29A9CC621B61Q34770719-681AB50C-92FB-4BEE-A626-F0D121BFBEBFQ34831085-B3CC4DE8-334F-494F-A499-87B0580644D5Q35428655-99DB1970-A0D9-4CE7-8FAE-43C6C99449CCQ35832365-DF4C488C-BD62-49C1-88EA-6F060C29A324Q35850882-316D2F21-5492-40B9-924C-21A03531415FQ37222064-7506C42F-4033-4093-8A75-973BA1B993C1Q37224591-D7F7B171-78DF-489F-8A1B-DCE6D9CF3B80Q37390973-A82E8225-98B2-4DDA-8A88-575DEBA35BF0Q38889621-C44F6A87-57B8-46FB-96E2-875D45403BAFQ39135703-F52092BA-6EE0-4757-80A1-9C8D99CFC8A1Q41337940-68848591-CF9D-40BC-AF74-C62D96862D78Q42106350-33F0FDC8-3A1E-467C-8DC3-19F05283FE49Q43752438-1423CDBB-6261-49E7-9CA2-5691361B2996Q50868047-8B1C4B2D-9845-4637-AED8-CE5FA333143AQ51488612-53B2639F-BA0E-479B-9E79-5516F5EDB13FQ52672873-62BB7B57-F78E-42FF-B6E0-C7E8B5A1E710Q53697011-39347290-90CA-4B89-A14D-972AEF7E349CQ55333132-512C6F96-753E-49AD-8B3C-3266166FA171
P2860
A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A human NK cell activation/inh ...... er susceptibility to NK cells.
@en
A human NK cell activation/inh ...... er susceptibility to NK cells.
@en-gb
A human NK cell activation/inh ...... er susceptibility to NK cells.
@nl
type
label
A human NK cell activation/inh ...... er susceptibility to NK cells.
@en
A human NK cell activation/inh ...... er susceptibility to NK cells.
@en-gb
A human NK cell activation/inh ...... er susceptibility to NK cells.
@nl
prefLabel
A human NK cell activation/inh ...... er susceptibility to NK cells.
@en
A human NK cell activation/inh ...... er susceptibility to NK cells.
@en-gb
A human NK cell activation/inh ...... er susceptibility to NK cells.
@nl
P2093
P50
P356
P1476
A human NK cell activation/inh ...... ter susceptibility to NK cells
@en
P2093
Adam Davison
G Eric Blair
Tim D Holmes
P304
P356
10.4049/JIMMUNOL.1000951
P407
P577
2010-12-29T00:00:00Z